Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
RVXCF
Primary Symbol:
T.RVX
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on May 16, 2022 7:53pm
RE:criminally stupid
Sad. Surly there are some big Shareholders of this company, not just a bunch of suckers like us holding all the shares with no say. McCrap has again pulled the wool over our collective eyes. This
...more
(16)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on May 16, 2022 1:01pm
RE:criminally stupid
accchhhhh,,,,,,,heading into the teens by mid summer,,,,,,massive dilution coming is the Markets guess...the Market of course is well connected to management and aware of any future activity ...this
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Nov 30, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(17)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on May 16, 2022 12:54pm
maybe something is up? IRAP/ISED & consultant update
i still stand by my comments with the criminally stupid communications from the co. leave MUCH to be desired. but doing our own DD...i swear i get more info from these online anonymous
...more
(17)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on May 16, 2022 11:16am
criminally stupid
still no updates as per their last release "Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
...more
(27)
•••
Jkj193741
X
View Profile
View Bullboard History
Post by
Jkj193741
on May 14, 2022 12:55pm
WSJ RVX INCOME TEPORT?
https://www.wsj.com/market-data/quotes/CA/RVX/financials
(14)
•••
Frogprince
X
View Profile
View Bullboard History
Post by
Frogprince
on May 10, 2022 10:59am
Finance
I should have said I bought the stock because of the backing of Eastern Capital.Everyone goes on about the science but those company has a problem with long term cash
(14)
•••
Frogprince
X
View Profile
View Bullboard History
Post by
Frogprince
on May 10, 2022 10:52am
Finance
Back to my favourite topic which got me kicked off Agoracom.The company releases Qtr finance next week so it's possible we may see something this week.However who are they going to sell stock to
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on May 09, 2022 8:49pm
RE:CORAL
McCrap let something slip in one of his pump sessions last year that they would be looking at long term results and long-Covid which struck me odd considering that the nature of the study was
...more
(17)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on May 09, 2022 2:51pm
CORAL
"Nowhere on the internet can I find a reference to CORAL other than in the RVX news release. How can we be measured against a new and undefined standard, a standard that based on my search
...more
(17)
•••
general360
X
View Profile
View Bullboard History
Post by
general360
on May 09, 2022 11:55am
same ole same ole...
wow, what a completely underwhleming NR this morning. i've been waiting for better news alllll year long...kinda par for the couse known as RVX. "we will update you regularly along the
...more
(14)
•••
Frogprince
X
View Profile
View Bullboard History
Comment by
Frogprince
on May 09, 2022 10:20am
RE:RE:Some news finally!
Good news DM was not mentioned and the Quote was from Ever send.Maybe we are seeing DM move back.
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on May 09, 2022 7:28am
RE:Some news finally!
Unfortunately it's crappy news....they are canning the current study, which we have all been waiting for UFB... August as a meeting date only ...long term Covid???? This will go on for at
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on May 09, 2022 7:22am
Some news finally!
Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on May 05, 2022 6:15am
RE:RE:Response from Investors Relations
Ya but Christmas in what year?? I lost all faith in this company yesterday as IR has responded again to my initial email, this time it was in my Trash Box and was worded a little
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >